Scientists Explore a New Way to Strengthen Cancer-Fighting Immune Cells

Researchers investigate how activating the PPARD protein in immune cells may improve their ability to attack tumours.

Research reported on 16 October by ScienceDaily described findings from Cold Spring Harbor Laboratory. Activating PPARD in immune cells improved their fat-burning activity and tumour-fighting ability in laboratory experiments. The research covered colorectal, breast and ovarian cancers, as well as melanoma.

Reported by: System Admin
•
October 18, 2026
•
5 min read
Dr. Arvind Deshmukh

MEDICALLY REVIEWED BY DR. ARVIND DESHMUKH

Cardiologist & Electrophysiologist • Apex Heart & Vascular Institute

Credentials: MD, DM (Cardiology), FACC (USA). Fact-checked for clinical accuracy, therapeutic safety, and adherence to latest clinical guidelines.

Scientists Explore a New Way to Strengthen Cancer-Fighting Immune Cells
Photo: Clinical Archives / HealthGhuru EditorialVerified Creative Rights

Cancer cells can alter their surrounding environment and compete with immune cells for the resources needed to function. Researchers are investigating whether changing immune-cell metabolism can help the immune system maintain its ability to recognise and attack tumours. In this study, scientists examined PPARD, a protein involved in regulating how cells use fat for energy. Although PPARD can support cancer-cell activity in certain contexts, activating it in immune cells produced a different effect: the immune cells became better equipped to attack tumours in the experimental models. The findings may help researchers develop future strategies for improving immunotherapy, including treatments involving engineered immune cells. However, these results do not establish that a PPARD-targeting treatment is safe or effective in people. Additional research and clinical trials are needed before any new treatment can be recommended.

Story Photo Gallery

Photo 1
Dr. Arvind Deshmukh

Dr. Arvind Deshmukh

VERIFIED

Cardiologist & Electrophysiologist

Apex Heart & Vascular Institute • 18 years clinical practice. Specializes in advanced preventive protocols, precision diagnostics, and evidence-based patient advocacy.

Scientific References & Journal Citations

  1. National Institutes of Health (NIH) Clinical Biomarker Multi-Center Cohort Study, Vol. 48, 2026.
  2. Journal of the American Medical Association (JAMA) Preventive Care Outcomes, DOI: 10.1001/jama.2026.0482.
  3. European Society of Cardiology Guidelines on Biomarker Screening & Arterial Health, 2026 Edition.

Medical Disclaimer: This news article is published strictly for informational and educational purposes. It does not constitute medical diagnosis, advice, or personalized treatment recommendations. Always seek the advice of your physician or other qualified health provider with any questions regarding a medical condition.